Clovis Oncology Inc (NASDAQ:CLVS)

76.46
Delayed Data
As of Feb 27
 -1.43 / -1.84%
Today’s Change
35.33
Today|||52-Week Range
93.33
+36.54%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 96.00, with a high estimate of 100.00 and a low estimate of 68.00. The median estimate represents a +25.56% increase from the last price of 76.46.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.73
Sales
$0.00
Reporting Date
May 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.64%
 
 
 
 
 
 
Growthannually -70.65%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually -84.80%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account